Samir Sunil Parekh MD

PubMed

• The Novel Immunocompetent Eµ-SOX11CCND1 Mouse Model Phenotypically and Molecularly Resembles Human Mantle Cell Lymphoma.
  Hedieh Jafari, Fiona Brown-Burke, Betsy Pray, Shelby Sloan, JoBeth Helmig-Mason
  Clinical Cancer Research. 2025-11-03
• 1 citations
  Comparison of MRI, [ 18 F]FDG-PET/CT, and [ 18 F]FDG-PET/MRI for Initial Staging of Multiple Myeloma : A Systematic Review and Meta-analysis.
  Mickael Tordjman, Murat Yuce, Amine Geahchan, Giuseppe Petralia, Roberto C Delgado Bolton
  Clinical Nuclear Medicine. 2025-11-01
• Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric Antigen Recepto...
  Zachary M Avigan, Jerrel Catlett, Saoirse Bodnar, Darren Pan, Adolfo Aleman
  Clinical Cancer Research. 2025-10-15

Abstracts/Posters

• Outcomes in Multiple Myeloma Patients Progressing on Lenalidomide Maintenance
  Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Genomic and Immunologic Analysis of Cmaf and Hypermutated Multiple Myeloma: Implications for Immunologic Therapy
  Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Multidimensional Single Cell Analysis Shows Increased T/NK Cell Subsets in Both Blood and Bone Marrow of Iberdomide (CC-220) Treated Relapsed/Refractory Multiple Myelo...
  Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• High Dimensional Immune Profiling in Smoldering Multiple Myeloma Identifies Novel Organizing Features of the Tumor Microenvironment
  Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ...
  Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Machine Learning Approach Identifies a 30-Gene Model That Predicts Sensitivity to Selinexor in Multiple Myeloma
  Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Targeting Hypersumoylation in Mantle Cell Lymphoma
  Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• ADAR1 Drives Disease Progression in Multiple Myeloma By Acting Both As an RNA Editor of Specific Transcripts and As a DNA Mutator of Their Cognate Genes
  Samir Parekh, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Increased HLA-E Expression Correlates with Early Relapse in Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Development of a Neoantigen Prediction Tool for Patient Stratification in Immuno-Oncology Trials 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018